Is vitamin D in rheumatoid arthritis a magic bullet or a mirage? the need to improve the evidence base prior to calls for supplementation

Arthritis and Rheumatism

Volumn 63, Issue 7, 2011, Pages 1763-1769

  Welsh, Paul ^a   Peters, Mike J L ^b   Sattar, Naveed ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; ADALIMUMAB; CALCIUM; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; VITAMIN D;

ACUTE PHASE RESPONSE; ANKYLOSING SPONDYLITIS; ARTHRITIS; BODY MASS; CIGARETTE SMOKING; DIET; DISEASE ACTIVITY; DISEASE SEVERITY; ETHNICITY; EXERCISE; HUMAN; INFLAMMATION; LATITUDE; LIFESTYLE MODIFICATION; NONHUMAN; NOTE; OSTEOPOROSIS; PHYSICAL ACTIVITY; PREVALENCE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; RISK FACTOR; SOCIAL CLASS; SYSTEMIC LUPUS ERYTHEMATOSUS; VITAMIN D DEFICIENCY; VITAMIN SUPPLEMENTATION;

ARTHRITIS, RHEUMATOID; DIETARY SUPPLEMENTS; HUMANS; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 79953786958     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.30341     Document Type: Note

References (68)

1. Bischoff-Ferrari HA, Willett WC, Wong JB, Giovannucci E, Dietrich T, Dawson-Hughes B,. Fracture prevention with vitamin D supplementation: a meta-analysis of randomized controlled trials. JAMA 2005; 293: 2257-64. (Pubitemid 40629192)
2. Wang S,. Epidemiology of vitamin D in health and disease. Nutr Res Rev 2009; 22: 188-203.
3. Holick MF,. Vitamin D deficiency. N Engl J Med 2007; 357: 266-81.
4. Brody JE,. What do you lack? Probably vitamin D. The New York Times 2010 July 27;Sect. D:7.
5. Guthrie C,. Top 10 medical breakthroughs: #10. Benefits of vitamin D. Time Magazine 2007 Sunday Dec 9; Top 10 Everything of 2007. URL: http://www.time.com/time/specials/2007/article/0,28804,1686204-1686252-1690393, 00.html.
6. The Vitamin D Council. URL: http://www.vitamindcouncil.org.
7. Knox S, Barr M, Wallace AM,. Increase in 25-hydroxyvitamin D workload: the Glasgow experience [abstract]. Ann Clin Biochem 2010; 47 Suppl 1: 95.
8. Wagner CL, Taylor SN, Hollis BW,. Does vitamin D make the world go 'round'? Breastfeed Med 2008; 3: 239-50.
9. Borradale D, Kimlin M,. Vitamin D in health and disease: an insight into traditional functions and new roles for the 'sunshine vitamin.' Nutr Res Rev 2009; 22: 118-36.
10. Levi R, Silver J,. Vitamin D supplementation after renal transplantation: how much vitamin D should we prescribe? Kidney Int 2009; 75: 576-8.
11. Norman AW, Bouillon R,. Vitamin D nutritional policy needs a vision for the future. Exp Biol Med (Maywood) 2010; 235: 1034-45.
12. Pelajo CF, Lopez-Benitez JM, Miller LC,. Vitamin D and autoimmune rheumatologic disorders. Autoimmun Rev 2010; 9: 507-10.
13. Zittermann A,. Vitamin D in preventive medicine: are we ignoring the evidence? Br J Nutr 2003; 89: 552-72. (Pubitemid 36592083)
14. Kerr GS, Sabahi I, Richards JS, Caplan L, Cannon GW, Reimold A, et al. Prevalence of vitamin D insufficiency/deficiency in rheumatoid arthritis and associations with disease severity and activity. J Rheumatol 2011; 38: 53-9.
15. Audran M, Briot K,. Critical reappraisal of vitamin D deficiency. Joint Bone Spine 2010; 77: 115-9.
16. Boullion R,. Vitamin D analogues: pharmacology and therapeutic uses. 8th European Congress of Endocrinology; 2006 April 1-5; Glasgow, UK.
17. Moro JR, Iwata M, von Andriano UH,. Vitamin effects on the immune system: vitamins A and D take centre stage. Nat Rev Immunol 2008; 8: 685-98.
18. Bartels LE, Hvas CL, Agnholt J, Dahlerup JF, Agger R,. Human dendritic cell antigen presentation and chemotaxis are inhibited by intrinsic 25-hydroxy vitamin D activation. Int Immunopharmacol 2010; 10: 922-8.
19. 2, responses. J Allergy Clin Immunol 2000; 106: 981-5.
20. Correale J, Ysrraelit MC, Gaitan MI,. Immunomodulatory effects of vitamin D in multiple sclerosis. Brain 2009; 132: 1146-60.
21. Cantorna MT, Hayes CE, DeLuca HF,. 1,25-dihydroxycholecalciferol inhibits the progression of arthritis in murine models of human arthritis. J Nutr 1998; 128: 68-72. (Pubitemid 28087178)
22. Larsson P, Mattsson L, Klareskog L, Johnsson C,. A vitamin D analogue (MC 1288) has immunomodulatory properties and suppresses collagen-induced arthritis (CIA) without causing hypercalcaemia. Clin Exp Immunol 1998; 114: 277-83. (Pubitemid 28505730)
23. 3 inhibits type II collagen-induced arthritis in rats. FEBS Lett 1994; 337: 248-50.
24. Adorini L,. Intervention in autoimmunity: the potential of vitamin D receptor agonists. Cell Immunol 2005; 233: 115-24. (Pubitemid 41074064)
25. Orbach H, Zandman-Goddard G, Amital H, Barak V, Szekanecz Z, Szucs G, et al. Novel biomarkers in autoimmune diseases: prolactin, ferritin, vitamin D, and TPA levels in autoimmune diseases. Ann N Y Acad Sci 2007; 1109: 385-400. (Pubitemid 47511381)
26. Patel S, Farragher T, Berry J, Bunn D, Silman A, Symmons D,. Association between serum vitamin D metabolite levels and disease activity in patients with early inflammatory polyarthritis. Arthritis Rheum 2007; 56: 2143-9. (Pubitemid 47173561)
27. Cutolo M, Otsa K, Laas K, Yprus M, Lehtme R, Secchi ME, et al. Circannual vitamin D serum levels and disease activity in rheumatoid arthritis: Northern versus Southern Europe. Clin Exp Rheumatol 2006; 24: 702-4. (Pubitemid 46138805)
28. Turhanoglu AD, Guler H, Yonden Z, Aslan F, Mansuroglu A, Ozer C,. The relationship between vitamin D and disease activity and functional health status in rheumatoid arthritis. Rheumatol Int 2010. E-pub ahead of print.
29. Welsh P, Peters MJ, McInnes IB, Lems WF, Lips PT, McKellar G, et al. Vitamin D deficiency is common in RA patients and linked to disease activity, but circulating levels are unaffected by TNFα blockade: results from a prospective cohort study. Ann Rheum Dis 2010. E-pub ahead of print.
30. 3 deficiency, disease activity and low bone mass in ankylosing spondylitis. Osteoporos Int 2005; 16: 1999-2004. (Pubitemid 41790919)
31. Borba VZ, Vieira JG, Kasamatsu T, Radominski SC, Sato EI, Lazaretti-Castro M,. Vitamin D deficiency in patients with active systemic lupus erythematosus. Osteoporos Int 2009; 20: 427-33.
32. Vieira VM, Hart JE, Webster TF, Weinberg J, Puett R, Laden F, et al. Association between residences in U.S. northern latitudes and rheumatoid arthritis: a spatial analysis of the Nurses' Health Study. Environ Health Perspect 2010; 118: 957-61.
33. Staples JA, Ponsonby AL, Lim LL, McMichael AJ,. Ecologic analysis of some immune-related disorders, including type 1 diabetes, in Australia: latitude, regional ultraviolet radiation, and disease prevalence. Environ Health Perspect 2003; 111: 518-23. (Pubitemid 36546533)
34. Merlino LA, Curtis J, Mikuls TR, Cerhan JR, Criswell LA, Saag KG,. Vitamin D intake is inversely associated with rheumatoid arthritis: results from the Iowa Women's Health Study. Arthritis Rheum 2004; 50: 72-7. (Pubitemid 38084289)
35. Costenbader KH, Feskanich D, Holmes M, Karlson EW, Benito-Garcia E,. Vitamin D intake and risks of systemic lupus erythematosus and rheumatoid arthritis in women. Ann Rheum Dis 2008; 67: 530-5. (Pubitemid 351498436)
36. Nielen MM, Van Schaardenburg D, Lems WF, Van De Stadt RJ, De Koning MH, Reesink HW, et al. Vitamin D deficiency does not increase the risk of rheumatoid arthritis: comment on the article by Merlino et al [letter]. Arthritis Rheum 2006; 54: 3719-20. (Pubitemid 44737186)
37. Lawlor DA, Davey Smith G, Kundu D, Bruckdorfer KR, Ebrahim S,. Those confounded vitamins: what can we learn from the differences between observational versus randomised trial evidence? Lancet 2004; 363: 1724-7. (Pubitemid 38670332)
38. Talwar D, McConnachie A, Welsh P, Upton M, O'Reilly D, Davey Smith G, et al. Which circulating antioxidant vitamins are confounded by socioeconomic deprivation. The MIDSPAN family study? PLoS One 2010; 5: e11312.
39. Querfeld U, Mak RH,. Vitamin D deficiency and toxicity in chronic kidney disease: in search of the therapeutic window. Pediatr Nephrol 2010; 25: 2413-30.
40. Drake MT, Maurer MJ, Link BK, Habermann TM, Ansell SM, Micallef IN, et al. Vitamin D insufficiency and prognosis in non-Hodgkin's lymphoma. J Clin Oncol 2010; 28: 4191-8.
41. Ameri P, Ronco D, Casu M, Denegri A, Bovio M, Menoni S, et al. High prevalence of vitamin D deficiency and its association with left ventricular dilation: an echocardiography study in elderly patients with chronic heart failure. Nutr Metab Cardiovasc Dis 2010; 20: 633-40.
42. Davey Smith G,. Specificity as a criterion for causation: a premature burial? Int J Epidemiol 2002; 31: 710-3.
43. Hypponen E, Berry D, Cortina-Borja M, Power C,. 25-hydroxyvitamin D and pre-clinical alterations in inflammatory and hemostatic markers: a cross sectional analysis in the 1958 British Birth Cohort. PLoS One 2010; 5: e10801.
44. Papadopoulos NG, Alamanos Y, Voulgari PV, Epagelis EK, Tsifetaki N, Drosos AA,. Does cigarette smoking influence disease expression, activity and severity in early rheumatoid arthritis patients? Clin Exp Rheumatol 2005; 23: 861-6. (Pubitemid 43040515)
45. McEntegart A, Morrison E, Capell HA, Duncan MR, Porter D, Madhok R, et al. Effect of social deprivation on disease severity and outcome in patients with rheumatoid arthritis. Ann Rheum Dis 1997; 56: 410-3. (Pubitemid 27345259)
46. Galloway P, McMillan DC, Sattar N,. Effect of the inflammatory response on trace element and vitamin status. Ann Clin Biochem 2000; 37: 289-97. (Pubitemid 30242758)
47. Reid D, Knox S, Talwar D, O'Reilly DJ, Blackwell S, Kinsella J, et al. Acute changes in the systemic inflammatory response is associated with transient decreases in circulating 25-hydroxyvitamin D concentrations following elective knee arthoplasty. Ann Clin Biochem 2010; 47 Suppl 1: 95-6.
48. Louw JA, Werbeck A, Louw ME, Kotze TJ, Cooper R, Labadarios D,. Blood vitamin concentrations during the acute-phase response. Crit Care Med 1992; 20: 934-41.
49. Straube S, Derry S, Moore RA, McQuay HJ,. Vitamin D for the treatment of chronic painful conditions in adults. Cochrane Database Syst Rev 2010;(1): CD007771.
50. Wang L, Manson JE, Song Y, Sesso HD,. Systematic review: vitamin D and calcium supplementation in prevention of cardiovascular events. Ann Intern Med 2010; 152: 315-23.
51. Autier P, Gandini S,. Vitamin D supplementation and total mortality: a meta-analysis of randomized controlled trials. Arch Intern Med 2007; 167: 1730-7. (Pubitemid 47403059)
52. Bolland MJ, Avenell A, Baron JA, Grey A, MacLennan GS, Gamble GD, et al. Effect of calcium supplements on risk of myocardial infarction and cardiovascular events: meta-analysis. BMJ 2010; 341: c3691.
53. Ross AC, Taylor CL, Yaktine AL, Del Valle HB,. Dietary reference intakes for calcium and vitamin D. Food and Nutrition Board, Institute of Medicine of the National Academies. URL: http://www.iom.edu/Reports/2010/Dietary-Reference- Intakes-for-Calcium-and-Vitamin-D.aspx.
54. Lightwood R,. Hypercalcaemia in infants and vitamin D. BMJ 1956; 2: 149.
55. Wang TJ, Zhang F, Richards JB, Kestenbaum B, Van Meurs JB, Berry D, et al. Common genetic determinants of vitamin D insufficiency: a genome-wide association study. Lancet 2010; 376: 180-8.
56. Royal College of Physicians, Bone and Tooth Society of Great Britain, National Osteoporosis Society. Glucocorticoid-induced osteoporosis: guidelines for prevention and treatment. Sudbury (UK): Lavenham Press; 2002. URL: http://bookshop.rcplondon.ac.uk/contents/pub89-a953a6c0-06c0-46d8-b79a- e951536d9070.pdf.
57. Glowacki J, Hurwitz S, Thornhill TS, Kelly M, LeBoff MS,. Osteoporosis and vitamin-D deficiency among postmenopausal women with osteoarthritis undergoing total hip arthroplasty. J Bone Joint Surg Am 2003; 85-A: 2371-7. (Pubitemid 37499647)
58. Hypponen E, Power C,. Hypovitaminosis D in British adults at age 45 y: nationwide cohort study of dietary and lifestyle predictors. Am J Clin Nutr 2007; 85: 860-8. (Pubitemid 46393520)
59. Tseng M, Giri V, Bruner DW, Giovannucci E,. Prevalence and correlates of vitamin D status in African American men. BMC Public Health 2009; 9: 191.
60. Craig SM, Yu F, Curtis JR, Alarcon GS, Conn DL, Jonas B, et al. Vitamin D status and its associations with disease activity and severity in African Americans with recent-onset rheumatoid arthritis. J Rheumatol 2010; 37: 275-81.
61. Zold E, Szodoray P, Gaal J, Kappelmayer J, Csathy L, Gyimesi E, et al. Vitamin D deficiency in undifferentiated connective tissue disease. Arthritis Res Ther 2008; 10: R123.
62. Glowacki J, Hurwitz S, Thornhill TS, Kelly M, LeBoff MS,. Osteoporosis and vitamin-D deficiency among postmenopausal women with osteoarthritis undergoing total hip arthroplasty. J Bone Joint Surg Am 2003; 85-A: 2371-7. (Pubitemid 37499647)
63. Braun-Moscovici Y, Toledano K, Markovits D, Rozin A, Nahir AM, Balbir-Gurman A,. Vitamin D level: is it related to disease activity in inflammatory joint disease? Rheumatol Int 2011; 31: 493-9.
64. Tahrani AA, Ball A, Shepherd L, Rahim A, Jones AF, Bates A,. The prevalence of vitamin D abnormalities in South Asians with type 2 diabetes mellitus in the UK. Int J Clin Pract 2010; 64: 351-5.
65. Ford L, Graham V, Wall A, Berg J,. Vitamin D concentrations in an UK inner-city multicultural outpatient population. Ann Clin Biochem 2006; 43: 468-73. (Pubitemid 44808271)
66. Clayton P, Singer R,. 25-hydroxyvitamin D levels in prevalent Australian dialysis patients. Nephrology (Carlton) 2009; 14: 554-9.
67. Evatt ML, Delong MR, Khazai N, Rosen A, Triche S, Tangpricha V,. Prevalence of vitamin D insufficiency in patients with Parkinson disease and Alzheimer disease. Arch Neurol 2008; 65: 1348-52.
68. Lee P, Eisman JA, Center JR,. Vitamin D deficiency in critically ill patients. N Engl J Med 2009; 360: 1912-4.